
Ultrasonography and MRI have emerged as crucial tools in diagnosing and managing inflammatory arthritis. However, current imaging methods need to be improved in distinguishing disease subsets and predicting individual patient outcomes accurately. The solution may lie in cutting-edge technology, including high-resolution imaging like peripheral quantitative computed tomography and ultra-high field MRI, functional and molecular-based techniques such as chemical exchange saturation transfer MRI and positron emission tomography, and artificial intelligence-driven data analysis. These innovations provide precise anatomical insights and non-invasive assessments of immune-metabolic inflammation, paving the way for earlier diagnoses, improved monitoring, and personalized treatment strategies.
Like
Save
Share